Christopher Hurn |
ORLANDO, FL--- Mortgage rates for commercial properties are
at their lowest ever and that means now is the best time to acquire commercial
property, says Christopher Hurn, chief executive officer of Mercantile
Capital Corp. in Orlando.
Since Jan. 1, Mercantile Capital Corp. has closed more than
85 commercial loans to finance projects totaling $364 million, and by the end
of the year that total could reach $450 million, Hurn projects.
Mercantile Capital ranks as one of the nation’s leading
providers of U.S. Small Business Administration (SBA) 504 loans for small
business owners who want to acquire or develop their own facilities.
Hurn said the SBA 504 loan program is offering a fixed 4.16
percent interest rate on a 20-year loan.
SBA 504 loan proceeds can be used for a variety of expenses
besides development or acquisitions of commercial real estate, Hurn said.
“Eligible uses for SBA 504 financing include commercial
property remodeling; conversions; expansions or renovations; improvements,
including grading, street work, utilities, parking lots and landscaping;
energy-efficient “green” projects; purchase of long-life machinery; furniture,
fixtures and equipment; contingency reserves; and soft costs,” Hurn explained.
As traditional lenders have yet to loosen their purse
strings, Hurn said SBA 504 lending ranks as perhaps the nation’s most effective
stimulus for economic recovery.
“Small business entrepreneurs all across the nation are
using 504 loans to secure their enterprises, add more workers and grow
businesses,” Hurn said, adding that “interest rates are the lowest ever and its
now a once-in-a-lifetime opportunity for entrepreneurs.”
For more information about this press release, contact:
Chris Hurn, Chief Executive Officer, Mercantile Capital
Corporation,
407-786-5040, ChrisHurn@MercantileCC.com
Geof Longstaff, Chairman, Mercantile Capital Corporation,
407-786-5040, Glongstaff@MercantileCC.com
Larry Vershel or Beth Payan, Larry Vershel Communications,
407-644-4142, Lvershelco@aol.com
No comments:
Post a Comment